These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

538 related items for PubMed ID: 10580423

  • 1. ATP-sensitive potassium channels and efaroxan-induced insulin release in the electrofusion-derived BRIN-BD11 beta-cell line.
    Chapman JC, McClenaghan NH, Cosgrove KE, Hashmi MN, Shepherd RM, Giesberts AN, White SJ, Ammälä C, Flatt PR, Dunne MJ.
    Diabetes; 1999 Dec; 48(12):2349-57. PubMed ID: 10580423
    [Abstract] [Full Text] [Related]

  • 2. BPDZ 154 activates adenosine 5'-triphosphate-sensitive potassium channels: in vitro studies using rodent insulin-secreting cells and islets isolated from patients with hyperinsulinism.
    Cosgrove KE, Antoine MH, Lee AT, Barnes PD, de Tullio P, Clayton P, McCloy R, De Lonlay P, Nihoul-Fékété C, Robert JJ, Saudubray JM, Rahier J, Lindley KJ, Hussain K, Aynsley-Green A, Pirotte B, Lebrun P, Dunne MJ.
    J Clin Endocrinol Metab; 2002 Nov; 87(11):4860-8. PubMed ID: 12414839
    [Abstract] [Full Text] [Related]

  • 3. Drug-induced desensitization of insulinotropic actions of sulfonylureas.
    Ball AJ, McCluskey JT, Flatt PR, McClenaghan NH.
    Biochem Biophys Res Commun; 2000 Apr 29; 271(1):234-9. PubMed ID: 10777708
    [Abstract] [Full Text] [Related]

  • 4. The alpha 2-adrenoceptor antagonist efaroxan modulates K+ATP channels in insulin-secreting cells.
    Chan SL, Dunne MJ, Stillings MR, Morgan NG.
    Eur J Pharmacol; 1991 Oct 29; 204(1):41-8. PubMed ID: 1687123
    [Abstract] [Full Text] [Related]

  • 5. Characterization of a KATP channel-independent pathway involved in potentiation of insulin secretion by efaroxan.
    Chan SL, Mourtada M, Morgan NG.
    Diabetes; 2001 Feb 29; 50(2):340-7. PubMed ID: 11272145
    [Abstract] [Full Text] [Related]

  • 6. Glucose dependence of imidazoline-induced insulin secretion: different characteristics of two ATP-Sensitive K+ channel-blocking compounds.
    Bleck C, Wienbergen A, Rustenbeck I.
    Diabetes; 2004 Dec 29; 53 Suppl 3():S135-9. PubMed ID: 15561901
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Glucose regulation of insulin secretion independent of the opening or closure of adenosine triphosphate-sensitive K+ channels in beta cells.
    Sato Y, Anello M, Henquin JC.
    Endocrinology; 1999 May 29; 140(5):2252-7. PubMed ID: 10218978
    [Abstract] [Full Text] [Related]

  • 11. PIP2 and ATP cooperatively prevent cytosolic Ca2+-induced modification of ATP-sensitive K+ channels in rat pancreatic beta-cells.
    Koriyama N, Kakei M, Nakazaki M, Yaekura K, Ichinari K, Gong Q, Morimitsu S, Yada T, Tei C.
    Diabetes; 2000 Nov 29; 49(11):1830-9. PubMed ID: 11078449
    [Abstract] [Full Text] [Related]

  • 12. Effects of sulphonylureas and diazoxide on insulin secretion and nucleotide-sensitive channels in an insulin-secreting cell line.
    Sturgess NC, Kozlowski RZ, Carrington CA, Hales CN, Ashford ML.
    Br J Pharmacol; 1988 Sep 29; 95(1):83-94. PubMed ID: 3146398
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of pinacidil, RP 49356 and nicorandil on ATP-sensitive potassium channels in insulin-secreting cells.
    Dunne MJ.
    Br J Pharmacol; 1990 Mar 29; 99(3):487-92. PubMed ID: 2158844
    [Abstract] [Full Text] [Related]

  • 15. Effects of imidazoline compounds on cytoplasmic Ca2+ concentration and ATP-sensitive K+ channels in pancreatic B-cells.
    Rustenbeck I, Kowalewski R, Herrmann C, Dickel C, Ratzka P, Hasselblatt A.
    Exp Clin Endocrinol Diabetes; 1995 Mar 29; 103 Suppl 2():42-5. PubMed ID: 8839253
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Essential role of the imidazoline moiety in the insulinotropic effect but not the KATP channel-blocking effect of imidazolines; a comparison of the effects of efaroxan and its imidazole analogue, KU14R.
    Bleck C, Wienbergen A, Rustenbeck I.
    Diabetologia; 2005 Dec 29; 48(12):2567-75. PubMed ID: 16283242
    [Abstract] [Full Text] [Related]

  • 18. Desensitization of insulin secretory response to imidazolines, tolbutamide, and quinine. II. Electrophysiological and fluorimetric studies.
    Rustenbeck I, Dickel C, Grimmsmanns T.
    Biochem Pharmacol; 2001 Dec 15; 62(12):1695-703. PubMed ID: 11755123
    [Abstract] [Full Text] [Related]

  • 19. Glucose activates both K(ATP) channel-dependent and K(ATP) channel-independent signaling pathways in human islets.
    Straub SG, James RF, Dunne MJ, Sharp GW.
    Diabetes; 1998 May 15; 47(5):758-63. PubMed ID: 9588447
    [Abstract] [Full Text] [Related]

  • 20. Imidazolines and the pancreatic B-cell. Actions and binding sites.
    Rustenbeck I, Köpp M, Ratzka P, Leupolt L, Hasselblatt A.
    Ann N Y Acad Sci; 1999 Jun 21; 881():229-40. PubMed ID: 10415921
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.